메뉴 건너뛰기




Volumn 27, Issue 1, 2011, Pages 119-126

Serum and cerebrospinal fluid uric acid levels in lewy body disorders: Associations with disease occurrence and amyloid-β pathway

Author keywords

Amyloid ; oxidative stress; Parkinson's disease; single nucleotide polymorphism; uric acid

Indexed keywords

AMYLOID BETA PROTEIN; URIC ACID;

EID: 80155190079     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110587     Document Type: Article
Times cited : (42)

References (34)
  • 3
    • 33750347347 scopus 로고    scopus 로고
    • Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
    • DOI 10.1038/nature05292, PII NATURE05292
    • Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795. (Pubitemid 44622683)
    • (2006) Nature , vol.443 , Issue.7113 , pp. 787-795
    • Lin, M.T.1    Beal, M.F.2
  • 4
    • 57049098604 scopus 로고    scopus 로고
    • Uric acid in Parkinson's disease
    • Schlesinger I, Schlesinger N (2008) Uric acid in Parkinson's disease. Mov Disord 23, 1653-1657.
    • (2008) Mov Disord , vol.23 , pp. 1653-1657
    • Schlesinger, I.1    Schlesinger, N.2
  • 5
    • 77958066708 scopus 로고    scopus 로고
    • Urate: A novel biomarker of Parkinson's disease risk, diagnosis and prognosis
    • Cipriani S, Chen X, Schwarzschild MA (2010) Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis. Biomark Med 4, 701-712.
    • (2010) Biomark Med , vol.4 , pp. 701-712
    • Cipriani, S.1    Chen, X.2    Schwarzschild, M.A.3
  • 6
    • 34447547493 scopus 로고    scopus 로고
    • Low plasma uric acid level in Parkinson's disease
    • DOI 10.1002/mds.21502
    • Annanmaki T, Muuronen A, Murros K (2007) Low plasma uric acid level in Parkinson's disease. Mov Disord 22, 1133-1137. (Pubitemid 47067223)
    • (2007) Movement Disorders , vol.22 , Issue.8 , pp. 1133-1137
    • Annanmaki, T.1    Muuronen, A.2    Murros, K.3
  • 11
    • 77951957859 scopus 로고    scopus 로고
    • Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community-based survey
    • Winquist A, Steenland K, Shankar A (2010) Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community-based survey.Mov Disord 25, 932-936.
    • (2010) Mov Disord , vol.25 , pp. 932-936
    • Winquist, A.1    Steenland, K.2    Shankar, A.3
  • 15
  • 18
    • 0023784368 scopus 로고
    • Acomparison of clinical and pathological features of young-and old-onset Parkinson's disease
    • GibbWR,Lees AJ (1988)Acomparison of clinical and pathological features of young-and old-onset Parkinson's disease. Neurology 38, 1402-1406.
    • (1988) Neurology , vol.38 , pp. 1402-1406
    • Gibbwrlees, A.J.1
  • 21
    • 0016823810 scopus 로고
    • "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician
    • Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
    • (1975) J Psychiatr Res , vol.12 , pp. 189-198
    • Folstein, M.F.1    Folstein, S.E.2    McHugh, P.R.3
  • 22
    • 0014082977 scopus 로고
    • Parkinsonism: Onset, progression and mortality
    • Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17, 427-442.
    • (1967) Neurology , vol.17 , pp. 427-442
    • Hoehn, M.M.1    Yahr, M.D.2
  • 23
    • 79951492876 scopus 로고    scopus 로고
    • Reduced but not oxidized cerebrospinal fluid glutathione levels are lowered in Lewy body diseases
    • Maetzler W, Schmid SP, Wurster I, Liepelt I, Gaenslen A, Gasser T, Berg D (2011) Reduced but not oxidized cerebrospinal fluid glutathione levels are lowered in Lewy body diseases. Mov Disord 26, 176-181.
    • (2011) Mov Disord , vol.26 , pp. 176-181
    • Maetzler, W.1    Schmid, S.P.2    Wurster, I.3    Liepelt, I.4    Gaenslen, A.5    Gasser, T.6    Berg, D.7
  • 24
    • 17644426053 scopus 로고    scopus 로고
    • Cognitive status correlates with neuropathologic stage in Parkinson disease
    • Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64, 1404-1410. (Pubitemid 40570509)
    • (2005) Neurology , vol.64 , Issue.8 , pp. 1404-1410
    • Braak, H.1    Rub, U.2    Jansen Steur, E.N.H.3    Del Tredici, K.4    De Vos, R.A.I.5
  • 26
    • 41149152169 scopus 로고    scopus 로고
    • Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
    • Jellinger KA, Attems J (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 115, 427-436.
    • (2008) Acta Neuropathol , vol.115 , pp. 427-436
    • Jellinger, K.A.1    Attems, J.2
  • 29
    • 33644623231 scopus 로고    scopus 로고
    • Insulin neuroprotection against oxidative stress in cortical neurons-involvement of uric acid and glutathione antioxidant defenses
    • Duarte AI, Santos MS, Oliveira CR, Rego AC (2005) Insulin neuroprotection against oxidative stress in cortical neurons-involvement of uric acid and glutathione antioxidant defenses. Free Radic Biol Med 39, 876-889.
    • (2005) Free Radic Biol Med , vol.39 , pp. 876-889
    • Duarte, A.I.1    Santos, M.S.2    Oliveira, C.R.3    Rego, A.C.4
  • 30
    • 17344371804 scopus 로고    scopus 로고
    • Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: Suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction
    • Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, Germeyer A, Steiner SM, Bruce-Keller AJ, Hutchins JB, Mattson MP (1998) Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 18, 687-697. (Pubitemid 28041905)
    • (1998) Journal of Neuroscience , vol.18 , Issue.2 , pp. 687-697
    • Keller, J.N.1    Kindy, M.S.2    Holtsberg, F.W.3    St. Clair, D.K.4    Yen, H.-C.5    Germeyer, A.6    Steiner, S.M.7    Bruce-Keller, A.J.8    Hutchins, J.B.9    Mattson, M.P.10
  • 31
    • 0037615209 scopus 로고    scopus 로고
    • Tyrosine nitration of a synaptic protein synaptophysin contributes to amyloid β-peptide-induced cholinergic dysfunction
    • DOI 10.1038/sj.mp.4001240
    • Tran MH,Yamada K, NakajimaA,Mizuno M, He J, Kamei H, Nabeshima T (2003) Tyrosine nitration of a synaptic protein synaptophysin contributes to amyloid beta-peptide-induced cholinergic dysfunction. Mol Psychiatry 8, 407-412. (Pubitemid 36609665)
    • (2003) Molecular Psychiatry , vol.8 , Issue.4 , pp. 407-412
    • Tran, M.H.1    Yamada, K.2    Nakajima, A.3    Mizuno, M.4    He, J.5    Kamei, H.6    Nabeshima, T.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.